As we reported previously [14,17], initial peak antibody responses after three-dose vaccination were similar between PWH and controls, and our new data additionally show that wild-type-specific and Omicron-specific IgG concentrations, ACE2 displacement and virus neutralization activities declined at similar rates among PWH and controls who remained COVID-19-naive throughout follow-up. The gene discussed is ACE2; the disease is COVID-19.